MedTrace Logo

Saphenous Vein Allografts for Coronary Bypass

NCT01386021 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2011-12-21

No results posted yet for this study

Summary

The primary objective of this observational study is to evaluate the function (patency) of cryopreserved saphenous vein allografts used as coronary artery bypass grafts (CABG) for patients with occlusive coronary artery disease.

Conditions

Sponsors & Collaborators

  • CryoLife, Inc.

    lead INDUSTRY

Principal Investigators

  • Valavanur A Subramanian, M.D.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2011-10-31
Completion
2011-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01386021 on ClinicalTrials.gov